Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
Little Rock, AR 72205
Summary
- Dr. Hui-Ming Chang is a professor at UAMS. She received her medical degree from National Taiwan University and two master degrees in epidemiology and physiology from Harvard Chan School of Public Health. Her residency and fellowship training were completed at Boston University Medical Center and Boston Children's Hospital, Harvard Medical School.
Education & Training
- Boston Children’s Hospital/Harvard Medical SchoolFellowship, Pediatric Anesthesiology, 1986 - 1988
- Boston Children's HospitalPost-Doctoral Fellowship, 1986 - 1988
- Boston University Medical CenterResidency, Anesthesiology, 1984 - 1986
- George Washington University School of MedicineInternship, Transitional Year, 1983 - 1984
- Harvard Chan School of Public HealthMaster of Science, Physiology, 1982 - 1983
- Harvard Chan School of Public HealthMaster of Public Health, Epidemiology, 1981 - 1982
- National Taiwan University College of MedicineClass of 1980
Certifications & Licensure
- TX State Medical License 1993 - 2026
- CA State Medical License 1995 - 2025
- MA State Medical License 1984 - 2025
- American Board of Anesthesiology Anesthesiology
Awards, Honors, & Recognition
- Medical Honoree American Heart Association, Heart Ball, Houston Texas, 2011
- Fleming and Davenport Awards 2000
- Harvard Scholar Harvard Alumni Association, Taipei, 1981
Clinical Trials
- Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane Start of enrollment: 2021 Sep 14
Publications & Presentations
PubMed
- 174 citationsSUMO: From Bench to Bedside.Hui-Ming Chang, Edward T.H. Yeh
Physiological Reviews. 2020-10-01 - 248 citationsCardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Hui-Ming Chang, Rohit Moudgil, TM Scarabelli, Tochukwu M. Okwuosa, Edward T.H. Yeh
Journal of the American College of Cardiology. 2017-11-14 - 268 citationsProtection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.Takafumi Okura, Limin Gong, Tetsu Kamitani, Torazo Wada, Izumi Okura
Journal of Immunology. 1996-11-15
Press Mentions
- UAMS Researchers Discover Potential Way to Control Immune ResponsesDecember 7th, 2021
- Cancer Patients at Heightened Risk for Arterial ThromboembolismAugust 14th, 2017
Grant Support
- Doxorubicin-induced Cardiotoxicity: the Role of Topoisomerase 2bNational Heart Lung and Blood Institute2015–2020
Committees
- American Academy of Pain Medicine, Scientific Review and Guidelines Committee 2018 - Present
- Executive Council, University of Texas Health Science Center at Houston 2005 - 2008
- Director, Board of Directors, American Academy of Pain Medicine 2003 - 2006
- Chair, Scientific Session, Annual Meeting, American Academy of Pain Medicine 2003 - 2003
- Scientific Advisory Committee, University Clinical Research Center, University of Texas at Houston & MD Anderson Cancer Center 1996 - 2006
Research History
- Co-Director, Center for Precision Medicine, University of Missouri2016 - Present
- Faculty, University of Texas Health Science Center at Houston1993 - 1997
- Faculty, Harvard Medical School, Massachusetts General Hospital1989 - 1993
- Post-Doctoral Research Fellow, Harvard Medical School, The Children's Hospital1986 - 1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: